# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Mar 16, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2022-03-16
- Accepted by EDGAR: Mar 16, 2022, 16:30 ET
- Period: not reported
- Accession: 0001140361-22-009784
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122009784/brhc10035309_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122009784/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122009784/brhc10035309_sc13da.htm

Filed Mar 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-009784. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.